Abstract:Background: Clostridioides difficile (C. difficile or C. diff) is a toxin-producing bacteria that is notorious for causing life-threatening diarrhea. Recent literature has investigated various effects of Clostridioides difficile infection (CDI) in cancer patients, but research into the impact of CDI on the development of cancer and its effects on the microbiome is limited. CDI predominately affects the colon, which urges consideration into the sequalae of infection. This study investigated the correlation between CDI and the incidence of colorectal carcinoma (CRC). Methods: A retrospective study (2010 - 2020) was conducted using a Health Insurance Portability and Accountability Act (HIPAA) compliant national database. The International Classification of Disease ninth and 10th Codes (ICD-9, ICD-10), Current Procedural Terminology (CPT), and National Drug Codes were used to identify CRC diagnosis, CDI, and matching or control parameters. Patients were matched for age, sex, Charlson Comorbidity Index (CCI), region of residence, and CDI treatment. An additional, but separate, query was executed to include obese patients with and without CDI, who were similarly matched and assessed for CRC. Statistical analyses were implemented to assess significance and estimate odds ratios (ORs). Results: CDI was associated with a decreased incidence of CRC (OR = 0.59, 95% confidence interval (CI): 0.55 - 0.63), and the difference was statistically significant (P < 2.2 × 10-16). CDI treatment, including appropriate antibiotics and fecal microbiota transplant (FMT), was controlled for in both infected and noninfected populations. Patients with a prior CDI who received relevant treatment were compared to patients with no history of CDI and received analogous treatment. Both populations subsequently developed CRC. Results remained statistically significant (P < 2.2 × 10-16) with a relative risk (RR) of 0.57 (95% CI: 0.54 - 0.60). Obesity was explored as a controlled variable in relation to CRC development in patients with and without prior CDI. Obese patients without a history of CDI were found to have a decreased risk of developing CRC. Results were statistically significant (P < 4.3 × 10-13) with an OR of 0.70 (95% CI: 0.63 - 0.77). Conclusions: This study shows a statistically significant correlation between CDI and decreased incidence of CRC. Additionally, there is a statistically significant correlation between obese patients with CDI and an increased incidence of CRC. Further research is needed to explore the mechanism of this striking relationship and the implications of CDIs on the microbiome.

S52 Morbidity of Clostridioides difficile in Necrotizing Pancreatitis: Insights from National Data

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

Clinical Risk Factors For Clostridium Difficile Infection In A Chinese Tertiary Care Hospital

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH

S1130 Prevalence and Inpatient Outcomes of Clostridioides difficile Infection in Inflammatory Bowel Disease

S752 Outcomes of Patients Infected With Clostridioides difficile With Comorbid Gastroparesis

An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization

Clostridioides Difficile Infection and Liver Cirrhosis – A Retrospective, Cohort Study

Incidence of Colorectal Cancer After Intestinal Infection Due to Clostridioides difficile

The outcomes of Clostridioides difficile infection in inpatient liver transplant population

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

Risk Factors, Outcomes and Epidemiology Associated with Clostridium Difficile Infection in Patients with Haematological Malignancies in a Tertiary Care Hospital in China

The Impact of Clostridioides Difficile Infection on Outcomes Among Kidney Transplant Recipients

Risk Factors for Clostridium Difficile Infection in Cirrhotic Patients.

Clostridium Difficile Colonization and Infection in Patients with Hepatic Cirrhosis

Clostridium difficile colitis portends poor outcomes in lower extremity orthopaedic trauma surgery

Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection

S232 Impact of Chronic Kidney Disease on Complications of Clostridioides difficile Infection - A Population-Based Study

Risk Factors Associated With Clostridium difficile-Associated Diarrhea

Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units